Delisted from NASDAQ in May 2023
Company logo

OBSV - ObsEva SA

NASDAQ -> Healthcare -> Biotechnology
Geneva, Switzerland
Type: Equity

OBSV price evolution
OBSV
(in millions $) 30 Oct 2022 30 Jul 2022 1 May 2022 30 Dec 2021
Current assets
Cash $9.68 $14.13 $57.55 $54.73
Short term investments
Net receivables $0.17 $0.18 $0.95 $3.56
Inventory
Total current assets $11.56 $48.68 $64.26 $63.52
Long term investments
Property, plant & equipment $0.36 $0.47 $0.58 $0.68
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $16.81 $54.18 $89.14 $88.99
Current liabilities
Accounts payable
Deferred revenue
Short long term debt
Total current liabilities $18.84 $16.33 $20.78 $23.51
Long term debt $32.92 $33.25 $25.73
Total noncurrent liabilities
Total debt
Total liabilities $19.96 $56.29 $61.18 $56.65
Shareholders' equity
Retained earnings -$452.92 -$446.51 -$415.54 -$436.98
Other shareholder equity $35.06 $33.24 $32.2
Total shareholder equity -$2.1 $27.96 $32.34
(in millions $) 30 Dec 2021 30 Dec 2020 30 Dec 2019 30 Dec 2018
Current assets
Cash $54.73 $31.18 $69.37 $138.64
Short term investments
Net receivables $3.56 $0.4 $1.04 $0.89
Inventory
Total current assets $63.52 $36.97 $74.77 $145.24
Long term investments
Property, plant & equipment $0.68 $1.58 $2.29 $0.32
Goodwill & intangible assets
Total noncurrent assets $28.48 $29.17 $22.2
Total investments
Total assets $88.99 $65.45 $103.94 $167.44
Current liabilities
Accounts payable $10.76 $8.43 $2.77
Deferred revenue
Short long term debt
Total current liabilities $23.51 $21.7 $19.47 $16.93
Long term debt $25.73 $25.3 $24.92
Total noncurrent liabilities $35.39 $35.52 $3.6
Total debt
Total liabilities $56.65 $57.09 $54.99 $20.52
Shareholders' equity
Retained earnings -$436.98 -$379.39 -$297.41 -$183.93
Other shareholder equity $32.2 $26.35 $21.91 $12.86
Total shareholder equity $32.34 $8.35 $48.95 $146.92
(in millions $) 30 Oct 2022 30 Jul 2022 1 May 2022 31 Jan 2022
Revenue
Total revenue $3.71
Cost of revenue
Gross Profit
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $4.34
Operating income
Income from continuing operations
EBIT
Income tax expense -$0.05
Interest expense $0.39
Net income
Net income -$12.06
Income (for common shares)
(in millions $) 31 Jan 2022 30 Dec 2020 30 Dec 2019 30 Dec 2018
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $67.54 $88.05 $62.87
Selling, general & administrative $12.18 $19.06 $14.3
Total operating expenses $79.7 $107.09 $77.15
Operating income -$79.7 -$107.09 -$77.15
Income from continuing operations
EBIT -$79.7 -$107.09 -$77.15
Income tax expense $0.03 $0.07 -$0.04
Interest expense -$2.7 -$1.19 -$1.19
Net income
Net income -$82.97 -$108.79 -$76.72
Income (for common shares) -$82.97 -$108.79 -$76.72
(in millions $) 30 Oct 2022 30 Jul 2022 1 May 2022 30 Dec 2021
Net income -$20.05
Operating activities
Depreciation $0.12
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$12.76
Investing activities
Capital expenditures
Investments
Total cash flows from investing $5.68 $5.68 $5.69
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings -$1.93
Total cash flows from financing -$19.32 $11.03 $12.19 $3.85
Effect of exchange rate -$0.34 -$0.34 $0.19 $0.75
Change in cash and equivalents -$45.05 -$9.61 $2.82 -$8.15
(in millions $) 30 Dec 2021 30 Dec 2020 30 Dec 2019 30 Dec 2018
Net income -$58.38 -$82.97 -$108.79 -$76.72
Operating activities
Depreciation $0.74 $0.72 $0.74 $0.11
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$70.3 -$70.77 -$90.61 -$63.94
Investing activities
Capital expenditures -$0.01 -$0.01 -$0.05 -$0.19
Investments
Total cash flows from investing $22.19 -$0.01 -$5.05 -$0.27
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings -$2.44 -$0.63 $24.16 $24.16
Total cash flows from financing $71.1 $32.25 $26.63 $91.65
Effect of exchange rate $0.56 $0.34 -$0.24 $0.36
Change in cash and equivalents $23.55 -$38.19 -$69.27 $27.8
Fundamentals
Market cap $8.74M
Enterprise value N/A
Shares outstanding 104.02M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q -81.53%
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share 0.09
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 1.75
Net debt/EBITDA N/A
Current ratio 0.61
Quick ratio N/A